Showing results (241-250 of 547) with videos related to

Sort By:
Pageof 55
Ebiomedicine|October 17, 2017
A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In VivoSeung Ho Shin, Do Young Lim, Kanamata Reddy, et al.
Oncogene|March 23, 2018
RSK2 is required for TRAF6 phosphorylation-mediated colon inflammationKe Yao, Sung-Young Lee, Cong Peng, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 10, 2013
Esculetin suppresses proliferation of human colon cancer cells by directly targeting β-cateninSung-Young Lee, Tae-Gyu Lim, Hanyong Chen, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 18, 2023
Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunitiesQian Liu, Ann M Bode, Xue Chen, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 7, 2024
Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapySiyuan Jia, Ann M Bode, Xue Chen, et al.
NPJ Precision Oncology|November 24, 2017
Protein activation mapping of human sun-protected epidermis after an acute dose of erythemic solar simulated lightJanine G Einspahr, Clara Curiel-Lewandrowski, Valerie S Calvert, et al.
Oncotarget|April 30, 2016
PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenograftsYuqiao Sheng, Kangdong Liu, Qiong Wu, et al.
Stem Cells (Dayton, Ohio)|October 15, 2010
Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cellsChul-Ho Jeong, Yong-Yeon Cho, Myoung-Ok Kim, et al.
Plos One|March 2, 2013
Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cellsYong-Yeon Cho, Dong Joon Kim, Hye Suk Lee, et al.
Stem Cell Research|November 12, 2013
JNK1 and 2 play a negative role in reprogramming to pluripotent stem cells by suppressing Klf4 activityKe Yao, Myoung Ok Ki, Hanyong Chen, et al.
Pageof 55